Baldwin Wealth Partners LLC MA trimmed its position in shares of Novartis AG (NYSE: NVS) by 10.1% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fun

2 Top Stocks to Buy and Hold for the Long Term

02:30am, Monday, 22'nd Dec 2025
Novartis has proved that it can navigate headwinds such as patent cliffs and a slow economy. Shopify's long-term ambitions are off to a great start, given its large addressable market and economic moa
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
Guru Stock PicksVanguard Health Care Fund has made the following transactions:Reduce in ARGX by 14.38%Sold out in PACSAdd in CLDX by 3.64%New position in PTGXCI
Officials pledge ‘massive savings' as companies agree to offer drugs at prices paid in other wealthy countries
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug
Basel, December 19, 2025 – Novartis, a leading global innovative medicines company, today announced it has reached an agreement with the US government that aims to lower the price of innovative medi

Novartis AG $NVS Shares Sold by Country Club Bank

04:44am, Thursday, 18'th Dec 2025
Country Club Bank lowered its position in shares of Novartis AG (NYSE: NVS) by 14.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fu
Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with the Trump administration towards that goal following a report they are close to a
The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as soon as Friday, Bloomberg News reported on Wednesday citing people familiar w
SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world's #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce's Agent
Corient Private Wealth LLC reduced its position in shares of Novartis AG (NYSE: NVS) by 2.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities an
Microsoft leads Zacks??? top research picks today, alongside Novartis and RTX, highlighting cloud, pharma innovation and defense demand shaping 2025.
B. Riley Wealth Advisors Inc. bought a new stake in Novartis AG (NYSE: NVS) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 9,22
Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by contract manufacturer Picea Robotics, saying operations and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE